231 related articles for article (PubMed ID: 21984595)
1. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
[TBL] [Abstract][Full Text] [Related]
2. Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
Akabane T; Tanaka K; Irie M; Terashita S; Teramura T
Xenobiotica; 2011 May; 41(5):372-84. PubMed ID: 21385103
[TBL] [Abstract][Full Text] [Related]
3. Predictability of metabolism of ibuprofen and naproxen using chimeric mice with human hepatocytes.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Uramaru N; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Dec; 40(12):2267-72. PubMed ID: 22936315
[TBL] [Abstract][Full Text] [Related]
4. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
[TBL] [Abstract][Full Text] [Related]
5. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
[TBL] [Abstract][Full Text] [Related]
6. Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics.
Sanoh S; Ohta S
Biopharm Drug Dispos; 2014 Mar; 35(2):71-86. PubMed ID: 24114658
[TBL] [Abstract][Full Text] [Related]
7. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.
Schulz-Utermoehl T; Sarda S; Foster JR; Jacobsen M; Kenna JG; Morikawa Y; Salmu J; Gross G; Wilson ID
Xenobiotica; 2012 Jun; 42(6):503-17. PubMed ID: 22201515
[TBL] [Abstract][Full Text] [Related]
9. Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications.
Diamond S; Boer J; Maduskuie TP; Falahatpisheh N; Li Y; Yeleswaram S
Drug Metab Dispos; 2010 Aug; 38(8):1277-85. PubMed ID: 20421447
[TBL] [Abstract][Full Text] [Related]
10. Physiologically Based Pharmacokinetic Modeling for Quantitative Prediction of Exposure to a Human Disproportionate Metabolite of the Selective Na
Asano D; Nakamura K; Nishiya Y; Shiozawa H; Takakusa H; Shibayama T; Inoue SI; Shinozuka T; Hamada T; Yahara C; Watanabe N; Yoshinari K
Drug Metab Dispos; 2023 Jan; 51(1):67-80. PubMed ID: 36273823
[TBL] [Abstract][Full Text] [Related]
11. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
[TBL] [Abstract][Full Text] [Related]
12. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver.
Kato K; Ohbuchi M; Hamamura S; Ohshita H; Kazuki Y; Oshimura M; Sato K; Nakada N; Kawamura A; Usui T; Kamimura H; Tateno C
Drug Metab Dispos; 2015 Aug; 43(8):1208-17. PubMed ID: 25979261
[TBL] [Abstract][Full Text] [Related]
13. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Crouch RD; Hutzler JM; Daniels JS
Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
[TBL] [Abstract][Full Text] [Related]
14. Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver.
Sanoh S; Naritomi Y; Fujimoto M; Sato K; Kawamura A; Horiguchi A; Sugihara K; Kotake Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
Xenobiotica; 2015; 45(7):605-14. PubMed ID: 25733030
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse.
Foster JR; Jacobsen M; Kenna G; Schulz-Utermoehl T; Morikawa Y; Salmu J; Wilson ID
Toxicol Pathol; 2012 Dec; 40(8):1106-16. PubMed ID: 22673116
[TBL] [Abstract][Full Text] [Related]
16. Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver.
Miyamoto M; Iwasaki S; Chisaki I; Nakagawa S; Amano N; Hirabayashi H
Xenobiotica; 2017 Dec; 47(12):1052-1063. PubMed ID: 27892765
[TBL] [Abstract][Full Text] [Related]
17. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Strelevitz TJ; Orozco CC; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
19. Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitor.
Liu L; Halladay JS; Shin Y; Wong S; Coraggio M; La H; Baumgardner M; Le H; Gopaul S; Boggs J; Kuebler P; Davis JC; Liao XC; Lubach JW; Deese A; Sowell CG; Currie KS; Young WB; Khojasteh SC; Hop CE; Wong H
Drug Metab Dispos; 2011 Oct; 39(10):1840-9. PubMed ID: 21742900
[TBL] [Abstract][Full Text] [Related]
20. Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans.
Nakada N; Kawamura A; Kamimura H; Sato K; Kazuki Y; Kakuni M; Ohbuchi M; Kato K; Tateno C; Oshimura M; Usui T
Biopharm Drug Dispos; 2016 Jan; 37(1):3-14. PubMed ID: 26352195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
